The Cannigma

FEBRUARY 1, 2023

Before we dive into the research, here’s the lowdown: Important takeaway points on cannabis and cancer Your situation is unique. Advocate for the rescheduling of cannabis to improve access to cannabis for research purposes, and scientific funding for novel cannabinoid-based cancer therapies. 1 So can cannabis cure cancer?

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

Cannabis Law Report

JUNE 21, 2021

Just about any industry benefits greatly from the proper use and evaluation of data. The tech giants of today are built mostly on data regarding their users, and advertisers rely on that data to more effectively target their efforts. How to Use the Data. RYAH Group Inc.

Data 105

Data Clinical Trials Research and Development Indica 105

Veriheal

NOVEMBER 24, 2021

For the first time ever, researchers will conduct a comprehensive state population health analysis to understand the impact of medical cannabis on consumers’ healthcare —and it’s all happening in Arkansas. A Deep Dive Into Cannabis Consumer Data. To fund the study, a $1.3 Hudson, Ph.D.,

Programs 84

Programs Research and Development Data Dispensary 84

NORML

SEPTEMBER 20, 2019

We also spoke with her attorneys, who explained why they believed the DEA broke the law by holding up long-promised medical marijuana research licenses. Sisley just entered the national spotlight, known as the research doctor who’d been unfairly fired from the University of Arizona for simply trying to study medical marijuana.

DEA 222

DEA Research and Development Clinical Trials Patients 222

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis research problem. Despite the massive amount of research publications that come out year over year, many of these studies face one or more research design limitations.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Veriheal

MAY 27, 2022

market alone represents a significant share of the worldwide market and, taking into account new projections published by New Frontier Data , U.S. Published as part of the data firm’s annual market update—which was carried out alongside FTI Consulting—the “ 2022 U.S. The post New Frontier Data Study Foresees U.S.

Data 98

Data Research and Development Cannabis Legislation 98

NewsMunchies

JULY 10, 2023

Artificial intelligence is a smarter, faster, and more effective pathway to drug development. With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds major potential to increase the accessibility of drugs and to treat diseases and conditions.

Treatment 58

Treatment Research and Development Microdosing Pharmaceutical 58

Cannabis Law Report

JUNE 18, 2021

CanMar Recruitment is looking for a Director of Business Development and Partnerships for our client in Montreal, Quebec. As Director of Business Development and Partnerships, you are responsible for leading and accelerating business analysis, sourcing, and deal flow activities. About Our Client. About the Role. Responsibilities.

Business 104

Business Research and Development Advocacy Data 104

Cannabis Law Report

AUGUST 1, 2021

Unfortunately, on the negative side, Connecticut yet again extended the 10% surcharge on the corporation business tax, and delayed and extended the phase-out of the capital base tax on corporations.

Research and Development 105

Research and Development Programs Legislation Business 105

Veriheal

JULY 18, 2023

The recently proposed bipartisan bill pledges $75 million towards research into the therapeutic potential of psychedelic substances in treating post-traumatic stress disorder (PTSD). The Grant Program Details The heart of this landmark legislation lies in the development of a robust grant program. In a bold and unprecedented move, U.S.

Treatment 94

Treatment Clinical Trials Research and Development Legislation 94

Cannabis Law Report

APRIL 28, 2021

Poster presentation to address the preclinical cannabidiol derivative for the potential treatment of psychiatric disorders BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc. Nasdaq:… Read More.

Pharmaceutical 98

Pharmaceutical Data Medicine Treatment 98

Veriheal

JUNE 22, 2020

Whether or not cannabis use during pregnancy causes physical, cognitive, or mental impairments later in life has been something scientists and researchers have been investigating for decades. Unfortunately, much of the research conducted thus far have not shown the whole picture or clinical implications for children in real life.

Research and Development 93

Research and Development Data Policy Education 93

Cannabis Law Report

JUNE 4, 2021

Nasdaq: AIKI ) (“AIkido” or the “Company”) today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual Meeting June 4 , 2021. The post AIkido Pharma Announces Positive Phase 1 Data Presented at ASCO on 225Ac-J591 appeared first on CannabisFN. Phase 2 trial underway.

Data 100

Data Research and Development Clinical Trials Therapy 100

Veriheal

NOVEMBER 30, 2021

Veriheal does not support illegally consuming therapeutic substances such as psilocybin but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting alternative therapies.

Research and Development 96

Research and Development Therapy Data Treatment 96

Veriheal

SEPTEMBER 14, 2021

The findings of a new study into cannabis use disorder (CUD) among veterans have been released by a team of researchers from Pennsylvania’s Center of Excellence in Substance Addiction Treatment and Education at the Corporal Michael J. Crescenz VA Medical Center. Their hypothesis was published in the American Journal of Psychiatry.

Consumption 88

Consumption Research and Development Treatment Programs 88

Veriheal

MAY 18, 2023

New guidelines for cannabis in chronic pain were recently published by a group of Canadian researchers. Featured in the journal Cannabis and Cannabinoid Research , the guidelines were compiled after researchers perused scientific databases for peer-reviewed English articles on cannabis and pain. used it in the last month.

Chronic Pain 89

Chronic Pain Treatment Research and Development Patients 89

Veriheal

JANUARY 31, 2023

Researchers Reach a Moral Conundrum According to Vikiana Clement, the former executive director of the Cannabis Education Task Force at Brooklyn’s Medgar Evers College and the researcher, purchasing cannabis from the illicit market may be the “true moral choice” depending on circumstances. This is a data analysis.”

Legalization 104

Legalization Research and Development Business Cannabis 104

The Cannigma

JANUARY 16, 2021

When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf. So Releaf app is an app that we released back in 2016.

Data 100

Data Research and Development Patients Strains 100

Cannabis Law Report

JULY 8, 2021

(NYSE American: YCBD, YCBDpA), one of the leading, and most highly trusted and recognized CBD companies, announced today that its recently formed division, cbdMD Therapeutics, has initiated talks with one of the leading US cannabinoid research institutes, to identify novel cannabinoids for therapeutic use. About cbdMD, Inc. cbdMD, Inc.

Research and Development 111

Research and Development Pets Cannabinoids Clinical Trials 111

Cannabis Law Report

DECEMBER 27, 2019

Clinical trials are medical research projects involving human participants. However, the costs of conducting a full-scale clinical trial can be prohibitive, posing barriers to research for cannabis companies. Cognizance VCT enables the generation of cost-effective quality data with ethical consent, on par with academic studies.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

Veriheal

APRIL 11, 2022

federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

MAY 29, 2022

is a Canadian company that researches, develops and grows psilocybin-producing mushrooms and functional mushrooms. Ciprick said there needs to be more outcome data and studies on the psilocybin-producing mushrooms to give that comfort level heading forward into introducing a larger market for the product. Optimi Health Corp.

Research and Development 52

Research and Development Clinical Trials Medicine Access 52

Cannabis Law Report

FEBRUARY 10, 2022

~Gary Allen, CEO, New Frontier Data. Our latest report, 22 for 2022: Cannabis Industry Assertions & Predictions, provides a data-centric blueprint for navigating near-term challenges and positioning for new opportunities in a burgeoning industry.

Data 52

Data Research and Development Hemp Legalization 52

Cannabis Law Report

JULY 28, 2021

The study was conducted by a respected contract research organization with deep expertise in preclinical oncology model development and drug testing and data corresponding to all studied cancer cell lines have now been reported to the Company. . – July 28, 2021) – PharmaDrug Inc.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

JULY 7, 2021

New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. MYMD-1 is being developed to treat autoimmune and age-related diseases, and to slow aging thereby increasing life-span. Acumen Research and Consulting confirmed TNF-? President, Director and Chief Medical Officer of MyMD.

Pharmaceutical 105

Pharmaceutical Data Clinical Trials Research and Development 105

Cannabis Law Report

MAY 29, 2022

Earlier this month, Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) urging both agencies to advance research on the therapeutic effects of psychedelic drugs. [1] Recent Regulatory Developments. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JULY 27, 2021

The initiative is part of Project Change Lives; Clever Leaves’ $25M product pledge to aid cannabis research in the U.S. The collaboration represents the Company’s first funded study with a research institution in the United States. organization to help advance scientific research into the potential medical benefits of cannabinoids.

Pharmaceutical 98

Pharmaceutical Research and Development Sativa Extraction 98

Cannabis Law Report

JULY 19, 2021

The data from the study is expected to be embedded into the RYAH MD platform, with the goal of enabling healthcare professionals to administer THC, CBD and terpenes in milliliters, which are then expected to automatically be converted into milligrams to allow for a customized, targeted patient inhalation session. billion by 2027.

Therapy 76

Therapy Data Research and Development Events 76

Cannabis Law Report

JANUARY 7, 2022

Our NXTecK™ platform is introducing scalable, aggregated, and normalized consumer data with an attribution model, so you know exactly where and how to focus your multi-channel strategies and achieve your digital marketing goals. Free Access to Equio ®. Sponsorship and Marketing Offerings.

Data 52

Data Research and Development Access Retail 52

SpeedWeed

JULY 7, 2021

However, it could take several years to build out those facilities, become GMP-certified and -compliant—which the Mexican government requires for the entire supply chain—gather stability data and so on, Detwiler said. View original article.

Research and Development 52

Research and Development Pharmaceutical Cannabinoids Cultivation 52

Cannabis Law Report

NOVEMBER 29, 2021

Medical marijuana has received more attention from legislators, scientists, researchers, clinicians, and the general public than any other topic. . Updated Researches On The Use Of Medical Marijuana . As part of a prior study, these claims used data from states that legalized recreational marijuana usage by the middle of 2018.

Legalization 52

Legalization Research and Development Marijuana Decriminalization 52

SpeedWeed

APRIL 2, 2021

Some of these claims were based on outdated research, but scientists are now discovering that alcohol , not weed, is responsible for these developmental issues. A new study published in the Biological Psychiatry journal is adding to the growing evidence that alcohol impairs adolescent brain development in ways that weed does not.

Research and Development 52

Research and Development History Media Collective 52

Cannabis Law Report

NOVEMBER 2, 2021

Earlier this month, the FDA released a seven-page plan to accelerate its research into the safety of cannabis-derived products. This emphasis on obtaining more information suggests the FDA is some time away from developing a robust, national CBD enforcement strategy. 01 November 2021. Perkins Coie LLP.

Safety 52

Safety Data Supply Chain Research and Development 52

SpeedWeed

MAY 18, 2021

Drug Enforcement Administration (DEA) quietly made an announcement that’s expected to have a profound and long-lasting impact on cannabis research and development in the United States. cannabis researchers. For years, NIDA and the DEA have promised to open up the sourcing of federally-approved research cannabis.

DEA 52

DEA Research and Development Data Cannabis 52

Cannabis Law Report

JULY 29, 2021

Scientists and researchers do not know exactly how or why these negative results occur, but they are still working on the question. Our main product is the Ehave Telemetry Portal, which is a mental health informatics platform that allows clinicians to make objective and intelligent decisions through data insights. Gabe@Ehave.com.

Research and Development 105

Research and Development Conditions Patients Data 105